Compare RDY & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | AVAV |
|---|---|---|
| Founded | 1984 | 1971 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 8.6B |
| IPO Year | 2001 | 2006 |
| Metric | RDY | AVAV |
|---|---|---|
| Price | $12.37 | $192.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 17 |
| Target Price | $16.90 | ★ $316.88 |
| AVG Volume (30 Days) | ★ 2.8M | 1.3M |
| Earning Date | 05-12-2026 | 03-10-2026 |
| Dividend Yield | ★ 0.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.72 | $135.55 |
| Revenue Next Year | $3.50 | $14.90 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.36 | $135.20 |
| 52 Week High | $15.67 | $417.86 |
| Indicator | RDY | AVAV |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 68.45 |
| Support Level | $12.19 | $175.07 |
| Resistance Level | $13.95 | $200.38 |
| Average True Range (ATR) | 0.20 | 10.01 |
| MACD | 0.11 | 5.38 |
| Stochastic Oscillator | 77.50 | 95.00 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.